cbdMD, Inc. (YCBD) Stock
cbdMD stock price chart
YCBD stock quote & key statistics
cbdMD annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $19.2M | -$2.0M | -$3.95 |
| FY2024 | $19.5M | -$3.7M | -$17.50 |
| FY2023 | $24.2M | -$22.9M | -$39.32 |
| FY2022 | $35.4M | -$70.1M | -$360.26 |
| FY2021 | $44.5M | -$23.4M | -$81.11 |
Fiscal year ending September 30. Source: company filings via EODHD.
About cbdMD, Inc.
cbdMD, Inc., based in Charlotte, North Carolina, is a leading producer and distributor of a diverse range of cannabidiol (CBD) products. The company owns and operates several prominent consumer hemp-based CBD brands, including cbdMD, Paw CBD, and cbdMD Botanicals. Under the cbdMD brand, the company offers a comprehensive array of CBD-infused products such as tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids, catering to various wellness needs.
A key facet of cbdMD's product lineup is its veterinarian-formulated offerings marketed under the Paw CBD brand. These products include CBD tinctures, chews, and topicals tailored specifically for pets, underscoring cbdMD's commitment to providing high-quality CBD solutions for both human and animal wellness. The company's distribution strategy encompasses direct sales through its e-commerce platform, presence on third-party e-commerce sites, partnerships with wholesalers, and placement in numerous brick-and-mortar retail outlets throughout the United States.
Founded in 2015 as Level Brands, Inc., cbdMD rebranded in May 2019 to reflect its focused mission on CBD-based products. With its headquarters in Charlotte, cbdMD continues to innovate within the CBD industry, leveraging its extensive product range and strategic distribution channels to meet the growing demand for CBD-infused wellness solutions across diverse consumer demographics.
cbdMD stock FAQ
What is the cbdMD stock ticker symbol?
cbdMD, Inc. trades on the NYSE American under the ticker symbol YCBD.
What sector and industry is cbdMD in?
cbdMD, Inc. is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.
How many employees does cbdMD have?
cbdMD, Inc. has about 42 full-time employees.
What were cbdMD's revenue and earnings last fiscal year?
cbdMD reported revenue of $19.2M and net income of -$2.0M in fiscal 2025, with earnings per share of -$3.95. Revenue declined 1.5% from the prior year.
When did cbdMD go public?
cbdMD stock began trading on April 29, 2019.
Drug Manufacturers - Specialty & Generic stocks
All Healthcare stocks →- ALKSAlkermes
- AMPHAmphastar Pharmaceuticals
- AMRXAmneal Pharmaceuticals
- ANIPANI Pharmaceuticals
- BCRXBioCryst Pharmaceuticals
- COLLCollegium Pharmaceutical
- EBSEmergent BioSolutions
- ELANElanco Animal Health
- EOLSEvolus
- HIMSHims & Hers Health
- INDVIndivior
- IRWDIronwood Pharmaceuticals
- KNSAKiniksa Pharmaceuticals
- LNTHLantheus
- NBIXNeurocrine Biosciences
- ORGOOrganogenesis
- PAHCPhibro Animal Health
- PBHPrestige Consumer Healthcare
- PCRXPacira BioSciences
- PRGOPerrigo
- SUPNSupernus Pharmaceuticals
- UTHRUnited Therapeutics
- VTRSViatris
- ZTSZoetis